Mesa BioTech Inc Respiratory Test Kit Accula™ Molecular Diagnostic Influenza A + B Nasal Swab Sam...
| Item Id | 1216939 |
| MF Id# | FAB1100CW |
| Brand | Accula™ |
| Manufacturer | Mesa BioTech Inc |
| Country of Origin | Unknown |
| Application | Respiratory Test Kit |
| CLIA Classification | CLIA Waived for Nasal Swabs |
| CLIA Classified | CLIA Waived Sample Dependent |
| Contents 1 | (25) Sterile Swabs for Nasal Collection, (25) Vials Nasal Swab Buffer, (25) Transfer Pipettes, (25) Test Cassettes, Flu A Positive / B Negative Control Swab, Flu B Positive / A Negative Control Swab |
| For Use With | For use with Accula Dock / Silaris Dock |
| Number of Tests | 25 Tests |
| Product Dating | McKesson Acceptable Dating: we will ship >= 90 days |
| Purchase Program Type | Standard Purchase |
| Reading Type | Machine Read |
| Sample Type | Nasal Swab Sample |
| Specialty | Molecular |
| Test Format | Cassette Format |
| Test Method | Nucleic Acid Amplification Test (NAAT) |
| Test Name | Influenza A + B |
| Test Type | Molecular Diagnostic |
| Time to Results | 30 Minute Results |
| UNSPSC Code | 41116144 |
Features
- Intended use The Accula™ Flu A/Flu B Test performed on the Accula™ Dock or Silaris™ Dock is a molecular in vitro diagnostic test utilizing polymerase chain reaction (PCR) and lateral flow technologies for the qualitative, visual detection and differentiation of influenza A and influenza B viral RNA
- The Accula™ Flu A/Flu B Test uses a nasal swab specimen collected from patients with signs and symptoms of respiratory infection
- The Accula™ Flu A/Flu B Test is a point of care Nucleic Acid Amplification Test (NAAT) for detection of influenza A virus and/or influenza B virus in patients with flu-like symptoms in approximately 30 minutes
- A Certificate of Waiver is required to perform this test in a CLIA Waived environment

